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Abstract The effects of progesterone, dehydroepiandrosterone 
sulfate and 17ß-estradiol on the synthesis and degradation of 
hyaluronate were investigated using human uterine cervix 
fibroblasts. The cells were incubated with [3H]glucosamine in 
the presence of the hormones and then [3H]hyaluronate was 
isolated from the medium. The changes in the radioactivity of 
[3H]hyaluronate showed that progesterone suppressed hyaluron-
ate synthesis by 22% of the control levels, while dehydroepian-
drosterone sulfate and 17ß-estradiol enhanced it by 22% and 
12% of the control levels, respectively. Furthermore, progester-
one induced degradation of high-molecular-weight [14C|hyal-
uronate into low-molecular-weight hyaluronate ( M r « 4 0 000). 
These results suggest that in cultured fibroblasts from the human 
uterine cervix progesterone converts hyaluronate metabolism 
from the synthesis phase to the degradation phase. 
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1. Introduction 
In human uterine cervix connective tissue, it has been re-
ported that the amount of hyaluronate increases markedly at 
the last stage of pregnancy and quickly decreases after partu-
rition [1-3]. However, the mechanism responsible for this rap-
id hyaluronate synthesis and degradation has not yet been 
clarified. 
Recently, Tanaka et al. [4] found that hyaluronidase activ-
ity was absent from human uterine cervix fibroblasts and that 
a hyaluronate-depolymerizing enzyme, endo-ß-N-acetylglucos-
aminidase [5], was activated in these cells by progesterone. In 
the present study, in order to elucidate hyaluronate metabo-
lism in the uterine cervix, the effects of hormones, especially 
progesterone, on the synthesis and degradation of hyaluronate 
were investigated using cultured fibroblasts derived from the 
human uterine cervix. The results showed that progesterone 
suppresses hyaluronate synthesis and, at the same time, con-
verts hyaluronate metabolism from the synthesis phase to the 
degradation phase in these cultured cells. 
2. Materials and methods 
2.1. Chemicals 
D-[6-3H]Glucosamine (specific activity 40 Ci/mmol) was purchased 
*Corresponding author. Fax: (81) (172) 39-5016. 
Abbreviations: DHAS, dehydroepiandrosterone sulfate; DMEM, 
Dulbecco's modified Eagle medium; HPLC, high-performance liquid 
chromatography 
from ICN Radiochemicals (Irvine, CA, USA). [14C]Hyaluronate 
(Aír=1.86X 10
6, specific activity 3.14 (iCi/mg) and non-radioactive 
hyaluronate (M r=1.90x 10°, l.OxlO
5 and 4.0X104) were the same 
as described previously [4]. Streptomyces hyaluronidase was purchased 
from Seikagaku (Tokyo, Japan), and actinase E was obtained from 
Kaken Seiyaku (Tokyo, Japan). Dehydroepiandrosterone sulfate 
(DHAS), 17ß-estradiol and progesterone were purchased from Sigma 
(St. Louis, MO, USA). All other reagents used were obtained from 
commercial sources. 
2.2. Cell culture 
Human uterine cervix and skin fibroblasts were cultured to conflu-
ence in Dulbecco's modified Eagle medium (DMEM) containing 10% 
fetal bovine serum in a humidified atmosphere of 5% C02/95% air at 
37°C, as described previously [4]. Cells at the second to sixth passage 
were used for the following experiments. The passage number did not 
affect the responses to hormones and other chemical reagents. 
2.3. Analysis of synthesized [3Hj'hyaluronate 
Uterine cervix fibroblasts were incubated in DMEM containing 
[3H]glucosamine (2 uCi/ml) for 48 h, and a medium fraction was 
obtained as described by Nakamura et al. [5]. As incorporation of 
[3H]glucosamine into the matrix and cell fractions was much smaller 
than that into the medium fraction in preliminary experiments, me-
dium fractions were used in this investigation. Ethanol saturated with 
NaCl (4 vols.) was then added to the medium fraction and the mixture 
was cooled and centrifuged. The precipitate was incubated with acti-
nase E in 50 mM Tris-HCl buffer (pH 8.0) overnight at 37°C. The 
reaction mixture was heated to 100°C for 3 min and then centrifuged. 
The supernatant was subjected to ethanol precipitation and the result-
ing precipitate was used as a [3H]glycosaminoglycan fraction. This 
fraction was dissolved in 100 mM sodium acetate buffer (pH 5.0) 
and an aliquot was subjected directly to high-performance liquid chro-
matography (HPLC). The rest of the solution was subjected to HPLC 
after Streptomyces hyaluronidase digestion for 12 h at 37°C. The 
HPLC was carried out on a Shodex OHpak KB-805 column 
(0.8X30 cm) (Showa Denko, Tokyo, Japan) eluted with 0.2 M 
NaCl at a flow rate of 0.5 ml/min. Fractions of 0.5 ml were collected 
and their radioactivity was counted using a liquid scintillation coun-
ter. Non-radioactive hyaluronates (Mr = 4 .0xl0
4 , 1.0 XlO5 and 
1.90X106) and hyaluronate tetrasaccharides obtained by digestion 
with Streptomyces hyaluronidase were used as molecular weight 
standards. 
For determination of [3H]hyaluronate, [3H]glycosaminoglycan frac-
tions were obtained and digested with Streptomyces hyaluronidase as 
described above. Ethanol saturated with NaCl (4 vols.) was added to 
the reaction mixture, which was then centrifuged. The supernatant 
was collected and its radioactivity was measured. The radioactivities 
of the medium fractions were defined as the amount of high-molec-
ular-weight hyaluronate. 
2.4. Effects of hormones on (iH]hyaluronate synthesis 
Uterine cervix fibroblasts were preincubated at 37°C in DMEM 
containing hormones (DHAS, 1X10~6 M; 17ß-estradiol, 1X10~7 
M or progesterone, 1 X 10~7 M). After 12 h the medium was removed 
and the cells were then incubated with fresh medium containing 
[3H]glucosamine (2 uCi/ml) and the same hormone for 48 h. The 
radioactivity of [3H]hyaluronate in the medium fraction was deter-
mined. The concentration of these hormones in the medium was based 
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Fig. 1. HPLC of [3H]hyaluronate synthesized by human uterine cer-
vix fibroblasts. Human uterine cervix fibroblasts were incubated for 
48 h in the presence of [3H]glucosamine. The medium with (•) or 
without (O) Streptomyces hyaluronidase treatment was then applied 
to a Shodex OHpak KB-805 column. Arrows indicate the elution 
positions of standard hyaluronate (Mr = 1.90 X10
6, 1.0 X105 and 
4.0 xlO4) and hyaluronate tetrasaccharides (0.8 K). V0, void vol-
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Fig. 2. Comparison of hyaluronate synthesis between human uterine 
cervix and skin fibroblasts. Incorporation of [3H]glucosamine into 
[3H]hyaluronate synthesis in cervix (O) and skin (•) fibroblasts was 
determined after incubation for 192 h. The radioactivity of 
[3H]hyaluronate from the medium fraction was defined as the 
amount of [3H]hyaluronate, which was expressed as hyaluronate per 
104 cells after the end of incubation. Data represent the mean val-
ues of three experiments. 
on their concentrations in the plasma of pregnant women at term 
[6,7]. 
3. Results 
3.1. Analysis of synthesized [3H]'hyaluronate 
Uterine cervix fibroblasts were incubated in medium con-
taining [3H]glucosamine for 48 h. The [3H]glycosaminoglycan 
fraction obtained from the medium fraction was subjected to 
HPLC. Two peaks were observed, and the peak eluted in the 
higher-molecular-weight region (retention time 6-10 min) was 
digested completely by Streptomyces hyaluronidase (Fig. 1). 
These results indicate that the 3H-labeled material of high 
molecular weight, which was synthesized by uterine cervix 
fibroblasts, was hyaluronate with an average molecular weight 
of about 1 X 106. 
3.2. Comparison of f3HJhyaluronate synthesis of uterine cervix 
and skin fibroblasts 
Uterine cervix and skin fibroblasts were incubated in me-
dium containing [3H]glucosamine and then hyaluronate syn-
thesis was compared. The incorporation of [3H]glucosamine 
into hyaluronate by these fibroblasts increased linearly with 
time, almost reaching a plateau after 120 h. After this time, 
the incorporation of [3H]glucosamine into hyaluronate by 
uterine cervix fibroblasts was about twice that by skin fibro-
blasts (Fig. 2). 
3.3. Effects of hormones on f3HJhyaluronate synthesis 
Uterine cervix and skin fibroblasts were preincubated in 
medium containing hormones (DHAS, 17ß-estradiol or pro-
gesterone) for 12 h. The medium was removed and the incu-
bation was continued with fresh medium containing 
[3H]glucosamine and the same hormone. After 48 h, the radio-
activities of hyaluronate synthesized by these cells were deter-
mined. In skin fibroblasts, the radioactivities of hyaluronate 
showed no difference between hormone-treated cells and con-
trol cells (Fig. 3A). On the other hand, in the presence of 10~7 
M progesterone the radioactivity of hyaluronate in uterine 
cervix fibroblasts was decreased by 22% of the control level. 
In contrast, in the presence of 10~6 M DHAS and 10~7 M 
17ß-estradiol, it was increased by about 22% and 12% of the 
control level, respectively (Fig. 3B). 
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Fig. 3. Effects of hormones on [3H]hyaluronate synthesis in human 
skin and uterine cervix fibroblasts. Human skin (A) and uterine cer-
vix (B) fibroblasts were incubated with [3H]glucosamine and hor-
mones. After 48 h, the incorporation of [3H]glucosamine into hyal-
uronate was determined as described in the text. [3H]Hyaluronate 
synthesis was expressed as hyaluronate per 104 cells after the end of 
incubation. Data are means ± S.D. of three experiments. *, signifi-
cantly different from control (P<0.01). I, control without hor-
mones; II, progesterone ( lx lO - 7 M); III, dehydroepiandrosterone 
sulfate (1X10-6 M); IV, 17ß-estradiol (1 X 10~7 M). 
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Fig. 4. Effects of progesterone on hyaluronate metabolism in uterine 
cervix fibroblasts. Human uterine cervix fibroblasts were incubated 
with both [3H]glucosamine and [14C]hyaluronate for 48 h, after 
which 10~7 M progesterone was added to the medium. After incu-
bation with progesterone for 5, 48 and 120 h, a portion of the me-
dium was recovered and the incorporation of [3H]glucosamine into 
hyaluronate (O) and the molecular weight of [14C]hyaluronate (•) 
were measured. The arrow indicates the time of addition of proges-
terone to the medium. 
3.4. Effects of progesterone on hyaluronate synthesis and 
degradation of uterine cervix fibroblasts 
Uterine cervix fibroblasts were incubated in medium con-
taining both [3H]glucosamine (2 uCi/ml) and [14C]hyaluronate 
(M r=1.86x 10
6, 0.09 uCi/ml, 14.3 ug/ml). After 48 h, 10"7 M 
progesterone was added to the medium and the incubation 
was continued. A portion of medium was recovered during 
incubation with progesterone, and the incorporation of 
[3H]glucosamine into hyaluronate and alterations in the chain 
length of [14C]hyaluronate were measured simultaneously. 
During incubation without progesterone, the incorporation 
of [3H]glucosamine into hyaluronate increased in a time-de-
pendent manner and the [14C]hyaluronate was not depolymer-
ized (Fig. 4). After progesterone had been added to the me-
dium, the incorporation of [3H]glucosamine into hyaluronate 
was suppressed and reached a plateau. At the same time, it 
was observed that [14C]hyaluronate began to be depolymer-
ized. After incubation with progesterone for 120 h, the hyal-
uronate had been depolymerized to a low-molecular-weight 
fragment (A/ r«40000) (Fig. 4). 
twice as much hyaluronate as the latter (Fig. 2). The molec-
ular weight of the hyaluronate synthesized by cervix fibro-
blasts was estimated to be about lXlO6 by gel-filtration 
HPLC (Fig. 1). In the cervix fibroblasts, hyaluronate synthesis 
was suppressed by progesterone, and stimulated by DHAS 
and 17ß-estradiol, respectively (Fig. 3B). In the contrast, these 
hormones were scarcely effective on hyaluronate synthesis in 
skin fibroblasts (Fig. 3A). These results suggest that the reg-
ulation of hyaluronate synthesis in uterine cervix fibroblasts is 
under hormonal control. 
Progesterone (10~7 M) was added to the medium after pre-
incubation of uterine cervix fibroblasts in the presence of both 
[3H]glucosamine and [14C]hyaluronate, and then incorpora-
tion of [3H]glucosamine into hyaluronate and changes in the 
chain length of [14C]hyaluronate were monitored. As a result, 
the synthesis of [3H]hyaluronate was suppressed and 
[14C]hyaluronate began to depolymerize to a low molecular 
weight almost immediately after the addition of progesterone 
(Fig. 4). These results indicate that progesterone induces rapid 
conversion of hyaluronate metabolism from the synthesis 
phase to the degradation phase. 
In our previous study [4], the progesterone antagonist 
RU38486 inhibited effectively the progesterone-induced de-
polymerization of hyaluronate in a dose-dependent manner. 
Therefore, it may be reasonable to consider that progesterone 
binds to its receptors on cervix fibroblasts [10], leading not 
only to the suppression of hyaluronate synthesis but also to 
the progression of hyaluronate degradation by inducing an 
endo-ß-N-acetylglucosaminidase, which differs from hyalu-
ronidase [5]. It has been reported that progesterone in the 
uterine cervix participates in the maintenance of firm connec-
tive tissue [11], inhibits uterine contractions [12], and sup-
presses the production of a neutrophil chemotactic factor/in-
terleukin-8 [13]. These results suggest that progesterone helps 
to keep the uterine cervix firm and avoids preterm delivery by 
suppressing hyaluronate synthesis and collagenolysis [11]. It is 
likely that further study of the regulation of hyaluronate me-
tabolism by progesterone will help to elucidate the mecha-
nisms of cervical changes during parturition. 
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4. Discussion References 
Hyaluronate is one of the primary constituents of the ex-
tracellular matrix of the human uterine cervix. It has been 
reported that during cervix ripening the amount of hyalu-
ronate increases to about 10 times the non-pregnant level, 
and decreases rapidly back to the non-pregnant level after 
parturition [1,3]. These dramatic changes suggest that hyalu-
ronate plays an important role in the regulation of cervix 
function during parturition. Although stimulation of hyalu-
ronate production by substances such as prostaglandin E2, 
prostaglandin F 2 a [8] and interleukin-loc [9] has been reported, 
the mechanisms of hyaluronate metabolism and its regulation 
in the cervix are unclear. 
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